You have 9 free searches left this month | for more free features.

cadonilimab

Showing 1 - 25 of 31

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cadonilimab in Recurrent or Metastatic Cervical Cancer

Not yet recruiting
  • Recurrent or Metastatic Cervical Cancer
  • Cadonilimab
  • (no location specified)
Nov 23, 2023

Cost-effectiveness Analysis of Cadonilimab in Treatment of

Not yet recruiting
  • Cervical Cancer
  • Cadonilimab
  • (no location specified)
Nov 18, 2023

Endometrial Cancer, Endometrial Adenocarcinoma Trial (Cadonilimab, Carboplatin, Cisplatin)

Not yet recruiting
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • Cadonilimab
  • +3 more
  • (no location specified)
Oct 7, 2023

Recurrent Glioblastoma Trial (fractionated radiotherapy, cadonilimab)

Not yet recruiting
  • Recurrent Glioblastoma
  • fractionated radiotherapy
  • cadonilimab
  • (no location specified)
Feb 20, 2023

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors Trial (Cadonilimab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Immune Checkpoint Inhibitors
  • Cadonilimab
  • +2 more
  • (no location specified)
Jun 1, 2023

Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)

Not yet recruiting
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • Tianjin, Tianjin, China
    Xuewei Ding
Aug 2, 2023

Lung Cancer Trial (Cadonilimab)

Not yet recruiting
  • Lung Cancer
  • Cadonilimab
  • (no location specified)
Mar 23, 2023

Colorectal Cancer Trial (cadonilimab, irinotecan, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • cadonilimab
  • +4 more
  • (no location specified)
Apr 20, 2023

Endometrial Cancer, Endometrial Adenocarcinoma Trial in Guangzhou (Cadonilimab, Lenvatinib)

Not yet recruiting
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Cetntre
Apr 9, 2023

Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Cadonilimab
  • Stereotactic body radiotherapy
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Jun 20, 2023

dMMR Colorectal Cancer Trial in Beijing (Cadonilimab)

Recruiting
  • dMMR Colorectal Cancer
  • Cadonilimab
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Apr 13, 2023

Bladder Cancer Trial in Tianjin (Cadonilimab)

Recruiting
  • Bladder Cancer
  • Cadonilimab
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 23, 2023

Cervical Cancer Trial in Wuhan (Cadonilimab, Anlotinib)

Recruiting
  • Cervical Cancer
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Apr 5, 2023

Nasopharyngeal Carcinoma Trial in Wuhan (Cadonilimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Cadonilimab
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Mar 27, 2023

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

Not yet recruiting
  • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  • Cadonilimab
  • +5 more
  • (no location specified)
Jul 17, 2023

Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)

Not yet recruiting
  • Esophagus Cancer
  • Cadonilimab
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Nov 20, 2023

Rectal Cancer, MSS Trial in Beijing (Cadonilimab, Oxaliplatin, Capecitabine)

Recruiting
  • Rectal Cancer
  • MSS
  • Cadonilimab
  • +2 more
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Apr 13, 2023

Non Small Cell Lung Cancer, Brain Metastases Trial (Cadonilimab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Brain Metastases
  • Cadonilimab
  • (no location specified)
Apr 2, 2023

NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Cadonilimab
  • +2 more
  • Wuhan, Hubei, China
    Qian Chu
Aug 18, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Cadonilimab, transjugular intrahepatic portosystemic shunt (TIPS))

Not yet recruiting
  • Hepatocellular Carcinoma
  • Cadonilimab
  • transjugular intrahepatic portosystemic shunt (TIPS)
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 30, 2023

Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Locally Advanced Operable
  • Cadonilimab
  • +2 more
  • Guangzhou, Guangdong, China
  • +1 more
Sep 4, 2023

Uterine Cervical Tumors, Cancer of Cervix, Cervical Cancer Trial (Cadonilimab, Nab paclitaxel)

Not yet recruiting
  • Uterine Cervical Neoplasms
  • +5 more
  • Cadonilimab
  • Nab paclitaxel
  • (no location specified)
Apr 9, 2023

Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)

Recruiting
  • Locally Advanced Colorectal Carcinoma
  • Cadonilimab
  • FOLFOX regimen
  • Beijing, Beijing, China
    Cancer Hospital/ National Cancer Center, Chinese Academy of Medi
Nov 23, 2023

NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

Recruiting
  • NSCLC Stage IV
  • +2 more
  • Cadonilimab
  • +2 more
  • Hefei, Anhui, China
  • +4 more
Apr 15, 2023

Immunotherapy, Second-line Treatment Trial in Guizhou (Cadonilimab)

Recruiting
  • Immunotherapy
  • Second-line Treatment
  • Cadonilimab
  • Guizhou, ZunYi, China
    The Second Affiliated Hospital of Zunyi Medical University
Jun 14, 2023